Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Ophthalmology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1614321

This article is part of the Research TopicNew Concepts, Advances, and Future Trends in Clinical Research on Eye DiseasesView all 44 articles

Investigation of Early Stage Cardiovascular-Kidney-Metabolic Syndrome on Retinal Structure and Function Evaluated by Optical Coherence Tomography Angiography

Provisionally accepted
  • 1The Sixth Affiliated Hospital of South China University of Technology, Foshan, Guangdong Province, China
  • 2Hangzhou Dianzi University, Hangzhou, Zhejiang Province, China
  • 3Foshan Technology Transfer Center of the Hong Kong University of Science and Technology, Foshan, Guangdong Province, China
  • 4Guangdong Provincial People's Hospital, Guangzhou, Guangdong Province, China

The final, formatted version of the article will be published soon.

The retina serves as a noninvasive window to visualize systemic health, with optical coherence tomography angiography (OCTA) enabling simultaneous assessment of retinal structural thickness and vascular density. Suboptimal Cardiovascular-Kidney-Metabolic (CKM) health status, defined by early stage of CKM syndrome may impact retinal neurovascular integrity, yet comprehensive OCTA-based evaluations remain limited and controversial. This study aimed to investigate retinal structural and vascular alterations in early stage CKM using OCTA and explore its potential as a biomarker tool. Methods A cross-sectional study included 2153 participants undergoing OCTA during health checks (2023-2024). Early stage CKM (stage 1-2) is characterized by abnormal levels of glucose, lipid profile, uric acid, or blood pressure. Retinal thickness and vessel density in nine ETDRS grid regions were measured. Univariate and multivariate logistic regression analyses identified associations between early stage CKM and OCTA parameters, adjusting for age and gender.Early stage CKM subjects (n=1,843, 94.5%) showed significantly reduced retinal thickness and vessel density across multiple regions compared to healthy controls (all p < 0.05).Multivariate analysis revealed that outer temporal thickness (OR=0.986, p < 0.001), outer superficial vessel density (OR=1.04, p=0.020), and inner superior vessel density (OR=0.962, p=0.010) were independent predictors of early stage CKM, alongside age and gender. Specific abnormalities, such as hypertension and diabetes, were linked to distinct regional decreases in thickness and density, suggesting dose-dependent impact of glycemic dysregulation on retinal health.Early stage CKM syndrome is associated with subtle retinal structural and vascular alterations detectable by OCTA, particularly in macular layers. OCTA-derived biomarkers, including outer temporal thickness and macular vessel density, may serve as noninvasive tools for evaluating systemic health status, offering promise for early detection of metabolic and cardiovascular risks.

Keywords: cardiovascular-kidney-metabolic syndrome, optical coherence tomography angiography, biomarker, Retinal thickness, Vessel density (VD)

Received: 18 Apr 2025; Accepted: 16 Jun 2025.

Copyright: © 2025 Liang, Liang, Yang, Li, Liang, Li, Zhang, Lao, Zhu, An, Liang and Ou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Chubin Ou, Guangdong Provincial People's Hospital, Guangzhou, 510317, Guangdong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.